美国大学生数学建模比赛的论文格式
- 1、下载文档前请自行甄别文档内容的完整性，平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益，请联系客服反馈,我们会尽快为您处理(人工客服工作时间：9:00-18:30)。
Contents
ⅠIntroduction (1)
1.1Problem Background (1)
1.2Previous Research (2)
1.3Our Work (2)
ⅡGeneral Assumptions (3)
ⅢNotations and Symbol Description (3)
3.1 Notations (4)
3.2 Symbol Description (4)
ⅣSpread of Ebola (5)
4.1 Traditional Epidemic Model (5)
4.1.1.The SEIR Model (5)
4.1.2 (6)
4.1.3 (6)
4.2 Improved Model (7)
4.2.1.The SEIHCR Model (8)
4.2.2 (9)
ⅤPharmaceutical Intervention (9)
5.1 Total Quantity of the Medicine (10)
5.1.1.Results from WHO Statistics (10)
5.1.2.Results from SEIHCR Model (11)
5.2 Delivery System (12)
5.2.1.Locations of Delivery (13)
5.2.2 (14)
5.3 Speed of Manufacturing (15)
ⅥOther Important Interventions (16)
6.1 Safer Treatment of Corpses (17)
6.2 Conclusion (18)
ⅦControl and Eradication of Ebola (19)
7.1 How Ebola Can Be Controlled (20)
7.2 When Ebola Will Be Eradicated (21)
ⅧSensitivity Analysis (22)
8.1 Impact of Transmission Rate (23)
8.2 Impact of the Incubation Priod (24)
ⅨStrengths and Weaknesses (25)
9.1 Strengths (26)
9.2 Weaknesses (27)
9.3 Future Work (28)
Letter to the World Medical Association (30)
References (31)
ⅠIntroduction
1.1.Promblem Background
1.2.Previous Research
1.3.Our Work
ⅡGeneral Assumptions
●
●
ⅢNotations and Symbol Description
3.1. Notataions
3.2. Symbol Description
Symbol Description
ⅣSpread of Ebola
4.1. Traditional Epidemic Model
4.1.1. The SEIR Model
4.1.2. Outbreak Data
4.1.3. Reslts of the SEIR Model
4.2. Improved Model
4.2.1. The SEIHCR Model
4.2.2. Choosing paameters
ⅤPharmaceutical Intervention 5.1. Total Quantity of the Medicine 5.1.1. Results from WHO Statistics
5.2. Delivery System
5.2.1. Locations of Delivery
5.2.2. Amount of Delivery
5.3. Speed of Manufacturong
5.4. Medicine Efficacy
ⅥOther Important Interventions 6.1. Safer Treatment of Corpses
6.2. Conclusion
ⅦControl and Eradication of Ebola 7.1. How Ebola Can Be Controlled
7.2. When Ebola Will Be Eradicated
ⅧSensitivity Analysis
8.1. Impact of Transmission Rate
8.2. Impact of Incubation Period
ⅨStrengths and Weaknesses 9.1. Strengths
●
●
●
9.2. Weaknesses
●
●
●
9.3.Future Work
Letter to the World Medical Association
To whom it may concern,
Best regards,
Team #32150